Bryan Liu

Director of the International Department, TianJin Cancer Hospital Airport Hospital

Member of the Ethics Committee at TianJin Cancer Hospital Airport Hospital

Founder of Bioocus Medical Group & CGT Centers

Professor of Scientific Research Management at the School of Life Sciences, Beijing Institute of Technology

Leader of the Party Working Group of the Cellular Immunotherapy Professional Committee at the China Association for the Promotion of Human Health Technology

Proficient in chemotherapy, targeted therapy, CAR-T therapy, and immunotherapy for hematologic malignancies.

Extensive clinical experience with malignant hematologic conditions such as refractory and relapsed leukemia, lymphoma, and multiple myeloma, adept at managing complex and challenging cases.

Achieved significant breakthroughs in treating recurrent cases using cellular immunotherapy for international patients, demonstrating notable therapeutic success.

Serves as an immunotherapy consultant for Apollo Hospitals in India, fostering cross-border medical collaboration

More than 10 years of clinical experience in the diagnosis and treatment of complex hematological diseases.

Participated in more than 300 cases of cellular immunotherapy for international patients, including cases of recurrent leukemia, lymphoma, Neuroblastoma, multiple myeloma, MG, SLE, SSC, Thalassemia, SCD, TDT.

Devoted to cellular immunotherapy and gene therapy for two decades.

Achieved significant results in CAR-T therapy, TILs therapy, NK therapy, and gene therapy.

Founded 4 Cellular and Gene therapy centers (CGT centers) in Beijing and Tianjin.